Report Detail

Medical Devices & Consumables Global and United States COVID-19 Nasal Swab Test Market Report & Forecast 2022-2028

  • RnM4448140
  • |
  • 31 May, 2022
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Summary:

Market Analysis and Insights: Global and United States COVID-19 Nasal Swab Test Market
This report focuses on global and United States COVID-19 Nasal Swab Test market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global COVID-19 Nasal Swab Test market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Foam Tipped Swabs accounting for % of the COVID-19 Nasal Swab Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital & Clinic was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the COVID-19 Nasal Swab Test market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global COVID-19 Nasal Swab Test Scope and Market Size
COVID-19 Nasal Swab Test market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global COVID-19 Nasal Swab Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the COVID-19 Nasal Swab Test market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the COVID-19 Nasal Swab Test market is segmented into
Foam Tipped Swabs
Non-Woven
Others
Segment by Application, the COVID-19 Nasal Swab Test market is segmented into
Hospital & Clinic
Laboratories & Diagnostics Centers
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and COVID-19 Nasal Swab Test Market Share Analysis
COVID-19 Nasal Swab Test market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in COVID-19 Nasal Swab Test business, the date to enter into the COVID-19 Nasal Swab Test market, COVID-19 Nasal Swab Test product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Roche Holding AG
Becton Dickinson & Company
3M Corporation
BioMerieux SA
Lucira Health
Mesa Biotech, Inc.
Siemens Healthineers AG
QIAGEN N.V.
Cepheid
LumiraDx Ltd.
Fluidigm Corporation
Quidel Corporation
GenMark Diagnostics, Inc.
Sherlock Biosciences
PrivaPath Diagnostics Limited
OraSure Technologies, Inc.


Table of Contents

    1 Study Coverage

    • 1.1 COVID-19 Nasal Swab Test Product Introduction
    • 1.2 Global COVID-19 Nasal Swab Test Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global COVID-19 Nasal Swab Test Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global COVID-19 Nasal Swab Test Sales in Volume for the Year 2017-2028
    • 1.3 United States COVID-19 Nasal Swab Test Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States COVID-19 Nasal Swab Test Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States COVID-19 Nasal Swab Test Sales in Volume for the Year 2017-2028
    • 1.4 COVID-19 Nasal Swab Test Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States COVID-19 Nasal Swab Test in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of COVID-19 Nasal Swab Test Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 COVID-19 Nasal Swab Test Market Dynamics
      • 1.5.1 COVID-19 Nasal Swab Test Industry Trends
      • 1.5.2 COVID-19 Nasal Swab Test Market Drivers
      • 1.5.3 COVID-19 Nasal Swab Test Market Challenges
      • 1.5.4 COVID-19 Nasal Swab Test Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 COVID-19 Nasal Swab Test Market Segment by Type
      • 2.1.1 Foam Tipped Swabs
      • 2.1.2 Non-Woven
      • 2.1.3 Others
    • 2.2 Global COVID-19 Nasal Swab Test Market Size by Type
      • 2.2.1 Global COVID-19 Nasal Swab Test Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global COVID-19 Nasal Swab Test Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global COVID-19 Nasal Swab Test Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States COVID-19 Nasal Swab Test Market Size by Type
      • 2.3.1 United States COVID-19 Nasal Swab Test Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States COVID-19 Nasal Swab Test Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States COVID-19 Nasal Swab Test Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 COVID-19 Nasal Swab Test Market Segment by Application
      • 3.1.1 Hospital & Clinic
      • 3.1.2 Laboratories & Diagnostics Centers
    • 3.2 Global COVID-19 Nasal Swab Test Market Size by Application
      • 3.2.1 Global COVID-19 Nasal Swab Test Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global COVID-19 Nasal Swab Test Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global COVID-19 Nasal Swab Test Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States COVID-19 Nasal Swab Test Market Size by Application
      • 3.3.1 United States COVID-19 Nasal Swab Test Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States COVID-19 Nasal Swab Test Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States COVID-19 Nasal Swab Test Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global COVID-19 Nasal Swab Test Competitor Landscape by Company

    • 4.1 Global COVID-19 Nasal Swab Test Market Size by Company
      • 4.1.1 Top Global COVID-19 Nasal Swab Test Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global COVID-19 Nasal Swab Test Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global COVID-19 Nasal Swab Test Sales by Manufacturer (2017-2022)
      • 4.1.4 Global COVID-19 Nasal Swab Test Price by Manufacturer (2017-2022)
    • 4.2 Global COVID-19 Nasal Swab Test Concentration Ratio (CR)
      • 4.2.1 COVID-19 Nasal Swab Test Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of COVID-19 Nasal Swab Test in 2021
      • 4.2.3 Global COVID-19 Nasal Swab Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global COVID-19 Nasal Swab Test Manufacturing Base Distribution, Product Type
      • 4.3.1 Global COVID-19 Nasal Swab Test Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers COVID-19 Nasal Swab Test Product Type
      • 4.3.3 Date of International Manufacturers Enter into COVID-19 Nasal Swab Test Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States COVID-19 Nasal Swab Test Market Size by Company
      • 4.5.1 Top COVID-19 Nasal Swab Test Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States COVID-19 Nasal Swab Test Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States COVID-19 Nasal Swab Test Sales by Players (2020, 2021 & 2022)

    5 Global COVID-19 Nasal Swab Test Market Size by Region

    • 5.1 Global COVID-19 Nasal Swab Test Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global COVID-19 Nasal Swab Test Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global COVID-19 Nasal Swab Test Sales in Volume by Region: 2017-2022
      • 5.2.2 Global COVID-19 Nasal Swab Test Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global COVID-19 Nasal Swab Test Market Size in Value by Region (2017-2028)
      • 5.3.1 Global COVID-19 Nasal Swab Test Sales in Value by Region: 2017-2022
      • 5.3.2 Global COVID-19 Nasal Swab Test Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America COVID-19 Nasal Swab Test Market Size YoY Growth 2017-2028
      • 6.1.2 North America COVID-19 Nasal Swab Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific COVID-19 Nasal Swab Test Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific COVID-19 Nasal Swab Test Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe COVID-19 Nasal Swab Test Market Size YoY Growth 2017-2028
      • 6.3.2 Europe COVID-19 Nasal Swab Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America COVID-19 Nasal Swab Test Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America COVID-19 Nasal Swab Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa COVID-19 Nasal Swab Test Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa COVID-19 Nasal Swab Test Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Abbott Laboratories
      • 7.1.1 Abbott Laboratories Corporation Information
      • 7.1.2 Abbott Laboratories Description and Business Overview
      • 7.1.3 Abbott Laboratories COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Abbott Laboratories COVID-19 Nasal Swab Test Products Offered
      • 7.1.5 Abbott Laboratories Recent Development
    • 7.2 Roche Holding AG
      • 7.2.1 Roche Holding AG Corporation Information
      • 7.2.2 Roche Holding AG Description and Business Overview
      • 7.2.3 Roche Holding AG COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Roche Holding AG COVID-19 Nasal Swab Test Products Offered
      • 7.2.5 Roche Holding AG Recent Development
    • 7.3 Becton Dickinson & Company
      • 7.3.1 Becton Dickinson & Company Corporation Information
      • 7.3.2 Becton Dickinson & Company Description and Business Overview
      • 7.3.3 Becton Dickinson & Company COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Becton Dickinson & Company COVID-19 Nasal Swab Test Products Offered
      • 7.3.5 Becton Dickinson & Company Recent Development
    • 7.4 3M Corporation
      • 7.4.1 3M Corporation Corporation Information
      • 7.4.2 3M Corporation Description and Business Overview
      • 7.4.3 3M Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 3M Corporation COVID-19 Nasal Swab Test Products Offered
      • 7.4.5 3M Corporation Recent Development
    • 7.5 BioMerieux SA
      • 7.5.1 BioMerieux SA Corporation Information
      • 7.5.2 BioMerieux SA Description and Business Overview
      • 7.5.3 BioMerieux SA COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 BioMerieux SA COVID-19 Nasal Swab Test Products Offered
      • 7.5.5 BioMerieux SA Recent Development
    • 7.6 Lucira Health
      • 7.6.1 Lucira Health Corporation Information
      • 7.6.2 Lucira Health Description and Business Overview
      • 7.6.3 Lucira Health COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Lucira Health COVID-19 Nasal Swab Test Products Offered
      • 7.6.5 Lucira Health Recent Development
    • 7.7 Mesa Biotech, Inc.
      • 7.7.1 Mesa Biotech, Inc. Corporation Information
      • 7.7.2 Mesa Biotech, Inc. Description and Business Overview
      • 7.7.3 Mesa Biotech, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Mesa Biotech, Inc. COVID-19 Nasal Swab Test Products Offered
      • 7.7.5 Mesa Biotech, Inc. Recent Development
    • 7.8 Siemens Healthineers AG
      • 7.8.1 Siemens Healthineers AG Corporation Information
      • 7.8.2 Siemens Healthineers AG Description and Business Overview
      • 7.8.3 Siemens Healthineers AG COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Siemens Healthineers AG COVID-19 Nasal Swab Test Products Offered
      • 7.8.5 Siemens Healthineers AG Recent Development
    • 7.9 QIAGEN N.V.
      • 7.9.1 QIAGEN N.V. Corporation Information
      • 7.9.2 QIAGEN N.V. Description and Business Overview
      • 7.9.3 QIAGEN N.V. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 QIAGEN N.V. COVID-19 Nasal Swab Test Products Offered
      • 7.9.5 QIAGEN N.V. Recent Development
    • 7.10 Cepheid
      • 7.10.1 Cepheid Corporation Information
      • 7.10.2 Cepheid Description and Business Overview
      • 7.10.3 Cepheid COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Cepheid COVID-19 Nasal Swab Test Products Offered
      • 7.10.5 Cepheid Recent Development
    • 7.11 LumiraDx Ltd.
      • 7.11.1 LumiraDx Ltd. Corporation Information
      • 7.11.2 LumiraDx Ltd. Description and Business Overview
      • 7.11.3 LumiraDx Ltd. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 LumiraDx Ltd. COVID-19 Nasal Swab Test Products Offered
      • 7.11.5 LumiraDx Ltd. Recent Development
    • 7.12 Fluidigm Corporation
      • 7.12.1 Fluidigm Corporation Corporation Information
      • 7.12.2 Fluidigm Corporation Description and Business Overview
      • 7.12.3 Fluidigm Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Fluidigm Corporation Products Offered
      • 7.12.5 Fluidigm Corporation Recent Development
    • 7.13 Quidel Corporation
      • 7.13.1 Quidel Corporation Corporation Information
      • 7.13.2 Quidel Corporation Description and Business Overview
      • 7.13.3 Quidel Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Quidel Corporation Products Offered
      • 7.13.5 Quidel Corporation Recent Development
    • 7.14 GenMark Diagnostics, Inc.
      • 7.14.1 GenMark Diagnostics, Inc. Corporation Information
      • 7.14.2 GenMark Diagnostics, Inc. Description and Business Overview
      • 7.14.3 GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 GenMark Diagnostics, Inc. Products Offered
      • 7.14.5 GenMark Diagnostics, Inc. Recent Development
    • 7.15 Sherlock Biosciences
      • 7.15.1 Sherlock Biosciences Corporation Information
      • 7.15.2 Sherlock Biosciences Description and Business Overview
      • 7.15.3 Sherlock Biosciences COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Sherlock Biosciences Products Offered
      • 7.15.5 Sherlock Biosciences Recent Development
    • 7.16 PrivaPath Diagnostics Limited
      • 7.16.1 PrivaPath Diagnostics Limited Corporation Information
      • 7.16.2 PrivaPath Diagnostics Limited Description and Business Overview
      • 7.16.3 PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 PrivaPath Diagnostics Limited Products Offered
      • 7.16.5 PrivaPath Diagnostics Limited Recent Development
    • 7.17 OraSure Technologies, Inc.
      • 7.17.1 OraSure Technologies, Inc. Corporation Information
      • 7.17.2 OraSure Technologies, Inc. Description and Business Overview
      • 7.17.3 OraSure Technologies, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 OraSure Technologies, Inc. Products Offered
      • 7.17.5 OraSure Technologies, Inc. Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 COVID-19 Nasal Swab Test Industry Chain Analysis
    • 8.2 COVID-19 Nasal Swab Test Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 COVID-19 Nasal Swab Test Distributors
    • 8.3 COVID-19 Nasal Swab Test Production Mode & Process
    • 8.4 COVID-19 Nasal Swab Test Sales and Marketing
      • 8.4.1 COVID-19 Nasal Swab Test Sales Channels
      • 8.4.2 COVID-19 Nasal Swab Test Distributors
    • 8.5 COVID-19 Nasal Swab Test Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on COVID-19 Nasal Swab Test. Industry analysis & Market Report on COVID-19 Nasal Swab Test is a syndicated market report, published as Global and United States COVID-19 Nasal Swab Test Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of COVID-19 Nasal Swab Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      2,902.90
      5,805.80
      3,453.45
      6,906.90
      549,895.50
      1,099,791.00
      322,091.00
      644,182.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report